380 related articles for article (PubMed ID: 9050793)
1. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH.
Charman WN; Porter CJ; Mithani S; Dressman JB
J Pharm Sci; 1997 Mar; 86(3):269-82. PubMed ID: 9050793
[TBL] [Abstract][Full Text] [Related]
2. A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption-Part I: Gastrointestinal pH.
Abuhelwa AY; Foster DJR; Upton RN
AAPS J; 2016 Sep; 18(5):1309-1321. PubMed ID: 27495120
[TBL] [Abstract][Full Text] [Related]
3. Food, gastrointestinal pH, and models of oral drug absorption.
Abuhelwa AY; Williams DB; Upton RN; Foster DJ
Eur J Pharm Biopharm; 2017 Mar; 112():234-248. PubMed ID: 27914234
[TBL] [Abstract][Full Text] [Related]
4. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
5. Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturation.
Yeap YY; Trevaskis NL; Quach T; Tso P; Charman WN; Porter CJ
Mol Pharm; 2013 May; 10(5):1874-89. PubMed ID: 23480483
[TBL] [Abstract][Full Text] [Related]
6. Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.
Custodio JM; Wu CY; Benet LZ
Adv Drug Deliv Rev; 2008 Mar; 60(6):717-33. PubMed ID: 18199522
[TBL] [Abstract][Full Text] [Related]
7. Simulating the postprandial stomach: physiological considerations for dissolution and release testing.
Koziolek M; Garbacz G; Neumann M; Weitschies W
Mol Pharm; 2013 May; 10(5):1610-22. PubMed ID: 23506381
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal contents in fasted state and post-lipid ingestion: in vivo measurements and in vitro models for studying oral drug delivery.
Di Maio S; Carrier RL
J Control Release; 2011 Apr; 151(2):110-22. PubMed ID: 21134406
[TBL] [Abstract][Full Text] [Related]
9. Understanding pharmacokinetic food effects using molecular dynamics simulation coupled with physiologically based pharmacokinetic modeling.
Turner DC; Yin F; Kindt JT; Zhang H
Biopharm Drug Dispos; 2012 Dec; 33(9):510-21. PubMed ID: 23065939
[TBL] [Abstract][Full Text] [Related]
10. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
Kataoka M; Fukahori M; Ikemura A; Kubota A; Higashino H; Sakuma S; Yamashita S
Eur J Pharm Biopharm; 2016 Apr; 101():103-11. PubMed ID: 26873006
[TBL] [Abstract][Full Text] [Related]
11. Investigation of some factors contributing to negative food effects.
Marasanapalle VP; Crison JR; Ma J; Li X; Jasti BR
Biopharm Drug Dispos; 2009 Mar; 30(2):71-80. PubMed ID: 19226652
[TBL] [Abstract][Full Text] [Related]
12. Lipids in the Stomach - Implications for the Evaluation of Food Effects on Oral Drug Absorption.
Koziolek M; Carrière F; Porter CJH
Pharm Res; 2018 Feb; 35(3):55. PubMed ID: 29423732
[TBL] [Abstract][Full Text] [Related]
13. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.
Shono Y; Jantratid E; Janssen N; Kesisoglou F; Mao Y; Vertzoni M; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2009 Sep; 73(1):107-14. PubMed ID: 19465123
[TBL] [Abstract][Full Text] [Related]
14. The dynamic gastric environment and its impact on drug and formulation behaviour.
Van Den Abeele J; Rubbens J; Brouwers J; Augustijns P
Eur J Pharm Sci; 2017 Jan; 96():207-231. PubMed ID: 27597144
[TBL] [Abstract][Full Text] [Related]
15. Predictive models for drugs exhibiting negative food effects based on their biopharmaceutical characteristics.
Marasanapalle VP; Crison JR; Devarakonda KR; Li X; Jasti BR
Drug Dev Ind Pharm; 2011 Dec; 37(12):1429-38. PubMed ID: 21615244
[TBL] [Abstract][Full Text] [Related]
16. Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part 1: oral solutions.
Thelen K; Coboeken K; Willmann S; Burghaus R; Dressman JB; Lippert J
J Pharm Sci; 2011 Dec; 100(12):5324-45. PubMed ID: 21993815
[TBL] [Abstract][Full Text] [Related]
17. PBPK models for the prediction of in vivo performance of oral dosage forms.
Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
[TBL] [Abstract][Full Text] [Related]
18. A physicochemical basis for the extensive intestinal lymphatic transport of a poorly lipid soluble antimalarial, halofantrine hydrochloride, after postprandial administration to dogs.
Khoo SM; Prankerd RJ; Edwards GA; Porter CJ; Charman WN
J Pharm Sci; 2002 Mar; 91(3):647-59. PubMed ID: 11920750
[TBL] [Abstract][Full Text] [Related]
19. Viscosity-mediated negative food effect on oral absorption of poorly-permeable drugs with an absorption window in the proximal intestine: In vitro experimental simulation and computational verification.
Cvijić S; Parojčić J; Langguth P
Eur J Pharm Sci; 2014 Sep; 61():40-53. PubMed ID: 24751672
[TBL] [Abstract][Full Text] [Related]
20. Prediction of positive food effect: Bioavailability enhancement of BCS class II drugs.
Raman S; Polli JE
Int J Pharm; 2016 Jun; 506(1-2):110-5. PubMed ID: 27067239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
